Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
What is your preferred empiric antibiotic escalation for a patient with chorioamnionitis with worsening signs of sepsis on single agent cefoxitin?
Related Questions
Do you give chronic antibiotic prophylaxis for recurrent UTIs, including Pseudomonas aeruginosa, in a patient with retained ureteral stents?
What workup is sufficient to determine if an aortic aneurysm is "mycotic/infectious" or not, in that you would not prescribe empiric antibiotic therapy?
Do you use oral beta-lactams to treat osteomyelitis?
Do you routinely recommend adjunctive rifampin therapy for the management of Staphylococcus aureus native vertebral osteomyelitis?
Do you recommend, based on current evidence, avoiding antimotility agents in patients with non-fulminant C. difficile infection who have no evidence of ileus?
Do you use metronidazole twice daily dosing for routine anaerobic coverage such as non-CNS, H. pylori, C. diff, or parasitic infections?
Do you give lifelong anti fungal therapy or a set time period of anti fungal therapy to patients who have vertebral hardware infection with some residual hardware that cannot be removed?
Are there situations where you would consider treating E faecalis or E faecium that grows from a respiratory culture?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
How have the results of the BALANCE trial, which demonstrated the noninferiority of 7 days of antibiotics compared to 14 days for non-S. aureus bloodstream infections, influenced your practice?
